Generic HPV vacc could cost under $15 per dose
A generic version of the human papillomavirus (HPV) vaccine is under development by Shantha Biotechnics, a Hyderabad, India-based vaccine producer, according to the Economic Times of India. The firm, 60% owned by France-based Merieux Alliance, has previously developed a generic vaccine against hepatitis B (marketed as Shanvac-B).
Shantha's managing director, Varaprasad Reddy, told the Economic Times: "our objective is to provide low-cost vaccines. We are already selling Shanvac-B in developing countries at 23 cents a vial against $70 by MNCs [multinational companies]."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze